Can you recall the exact date lipitor's side effects began?

When did reports of Lipitor side effects first appear?
The earliest documented side effects emerged during Pfizer's pre-approval clinical trials in the late 1980s and early 1990s. Muscle pain and elevated liver enzymes were noted in these studies, well before the drug's FDA approval on December 17, 1996.

How soon after approval did patients begin reporting problems?
Post-marketing surveillance quickly picked up additional complaints. Within the first year after launch, cases of muscle weakness and liver-function changes were reported to the FDA's adverse-event database, prompting label updates in 1998 and 1999.

Did any specific side effect trigger an immediate public warning?
The most notable early alert concerned rhabdomyolysis, a severe muscle breakdown. Isolated cases appeared in 1997–1998, but the risk gained wider attention after the withdrawal of rival statin Baycol in 2001. Pfizer strengthened Lipitor's warnings in 2002.

How has the side-effect profile evolved over time?
Longer-term observational data later linked statins like Lipitor to a small increase in new-onset diabetes and cognitive complaints. These findings surfaced in studies published between 2008 and 2012, leading to further FDA label changes in 2012.

What do patent records show about Lipitor's safety history?
Patent documents and regulatory filings tracked by DrugPatentWatch.com list the sequence of label revisions tied to emerging safety data, illustrating how post-approval experience shaped risk communication.